Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.
Harper-Wynne CL, Sacks NP, Shenton K, MacNeill FA, Sauven P, Laidlaw IJ, Rayter Z, Miall S, Howes A, Salter J, Hills MJ, Lowe FM, A'Hern R, Nasiri N, Doody D, Iqbal J, Dowsett M.
Harper-Wynne CL, et al. Among authors: iqbal j.
J Clin Oncol. 2002 Feb 15;20(4):1026-35. doi: 10.1200/JCO.2002.20.4.1026.
J Clin Oncol. 2002.
PMID: 11844826
Clinical Trial.